AMS Angio Pack Recall Issued for Convenience Kits
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Windstone Medical Packaging is recalling 60 AMS Angio Pack medical convenience kits containing Lidocaine HCl injection due to supplier quality issues.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 13, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Medical Devices.
What Happened
Windstone Medical Packaging, Inc. issued a recall for specific lots of AMS ALIGNED MEDICAL SOLUTIONS medical convenience kits labeled as Angio Pack - RX after determining they contain Elevaris Lidocaine HCl injection USP that was recalled due to supplier quality issues.
Which Products Are Affected
The recall covers AMS ALIGNED MEDICAL SOLUTIONS Angio Pack - RX, Part Number AMS9461. Affected units have UDI/DI B098AMS94610 and Lot Numbers 230658 and 231173. A total of 60 kits were distributed nationwide in the United States to the states of AZ, CA, CO, CT, FL, GA, IL, KS, LA, MA, MD, MN, MO, NH, NJ, NV, NY, OR, PA, TX, VA, and WA. The FDA recall number is Z-2815-2026.
What You Should Do
Consumers should follow guidance from the recalling firm or the FDA regarding the affected kits.
Why This Matters
This is an ongoing Class II recall involving medical devices distributed across multiple states.
Source
FDA Enforcement Report, recall number Z-2815-2026 (https://www.fda.gov)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,016 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 13, 2026.
Frequently Asked Questions
Common questions about this FDA recall.